Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpe Special Opp Regulatory News (ESO)

Share Price Information for Epe Special Opp (ESO)

Share Price is delayed by 15 minutes
Get Live Data
237.00    -1.00 (-0.42%)
Bid:
232.00
Ask:
242.00
Spread: 10.00 (4.31%)
Market Cap: £58.41m
ESO Live PriceLast checked at - London Stock Exchange

Intraday Epe Special Opp Share Chart

Investment

4 Jul 2025 10:00

RNS Number : 8005P
EPE Special Opportunities Limited
04 July 2025
 

EPE Special Opportunities Limited

 

Investment

 

 

EPE Special Opportunities Limited ("ESO" or the "Company") is pleased to announce that on 2 July 2025, ESO Investments 1 Limited (an undertaking of ESO, in which it is the sole investor) ("ESO 1") acquired a majority stake in Prism Holdco (2025) Limited (the "Target" or, together with undertakings, the "Target Group") (the "Transaction").

 

The Target Group owns the LSA International brand which designs, develops and distributes a wide range of award-winning interior products, including glassware, tableware and interior accessories. The Target Group has achieved a strong reputation for design led, contemporary products centred on quality, craftmanship and sustainability. The Target Group supplies a broad range of premium retailers, hospitality partners and distributors in the UK and international markets, as well as operating e-commerce and marketplace channels. ESO will assist the Target Group's future growth ambitions, accelerated by collaboration and integration with the Company's existing portfolio company in the sector, the Rayware Group.

 

As part of the transaction, ESO 1 is investing up to £2.1 million (funded by cash reserves advanced from ESO) to fund the paydown of bank debt (£1.1 million) and to support working capital (£1.0 million), and ESO issued 298,013 shares to the former shareholders of LSA International. Following the Transaction, ESO has available cash of £7.1 million. The Transaction has no impact on the Company's net asset value.

 

Application has been made for the admission to trading on AIM of the 298,013 consideration shares which is expected to occur on 9 July 2025. Following admission, ESO will have 28,396,073 ordinary shares in issue with each ordinary share carrying the right to one vote. The total number of voting rights in the Company is therefore 28,396,073. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interests in, the Company under the FCA's Disclosure and Transparency Rules.

 

About ESO

 

· ESO is an AIM-quoted, private equity investment company, whose objective is to provide long-term return on equity for its shareholders by investing in SMEs.

 

· ESO seeks to invest up to £30 million into companies with strong fundamentals, including defensible competitive positioning and high levels of cash generation, and aims to partner with outstanding management teams to combine operational and financial expertise in each investment.

 

· ESO will consider most industry sectors, including consumer, retail, manufacturing, financial services and the broader services sectors, and can make direct investments, special situations investments, primary and secondary fund investments and private investments in public equities.

 

· ESO's investment horizon is flexible, creating the opportunity to maximise value via optimising exit timing, compounding returns and re-investing behind successful management teams.

 

The person responsible for releasing this information on behalf of the Company is Amanda Robinson of Langham Hall Fund Management (Jersey) Limited.

 

Enquiries:

 

EPIC Investment Partners LLP

+44 (0) 207 269 8860

Rupert Palmer

Langham Hall Fund Management (Jersey) Limited

+44 (0) 153 488 5200

Amanda Robinson

 

Cardew Group Limited

+44 (0) 207 930 0777

Richard Spiegelberg

 

Deutsche Numis

+44 (0) 207 260 1000

Nominated Advisor:

Stuart Skinner / Emma Brown

Corporate Broker:

Charles Farquhar

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRIMPTMTIMMFA
Date   Source Headline
2nd Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSAnnual Financial Report
5th Mar 20247:00 amRNSHolding(s) in Company
13th Feb 20246:00 pmRNSDirector/PDMR Shareholding
8th Feb 20244:45 pmRNSTrading Update
8th Feb 20247:00 amRNSInterest Payment on Unsecured Loan Notes
10th Jan 20247:00 amRNSNet Asset Value(s)
20th Dec 20237:00 amRNSHolding(s) in Company
20th Dec 20237:00 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSNet Asset Value(s)
9th Nov 20237:00 amRNSNet Asset Value(s)
26th Oct 20236:29 pmRNSDirector/PDMR Shareholding
17th Oct 20236:30 pmRNSHolding(s) in Company
10th Oct 20234:30 pmRNSNet Asset Value(s)
3rd Oct 20236:00 pmRNSDirector Retirement
20th Sep 20237:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSHalf-year Report
4th Sep 20235:00 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSHolding(s) in Company
1st Aug 20237:00 amRNSInterest Payment on Unsecured Loan Notes
26th Jul 20237:00 amRNSUpdate on Share Buy Backs
24th Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSExtension of Unsecured Loan Notes
21st Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20239:30 amRNSAnnouncement of ZDP Share Buybacks
18th Jul 202310:00 amRNSPortfolio Update
11th Jul 20237:00 amRNSNet Asset Value(s)
30th Jun 20237:01 amRNSProposed Extension of Unsecured Loan Notes
30th Jun 20237:00 amRNSResult of AGM
12th Jun 20237:00 amRNSNet Asset Value(s)
19th May 20237:00 amRNSNotice of AGM
17th May 20237:00 amRNSPosting of Annual Report and Accounts
12th May 20237:00 amRNSHolding(s) in Company
12th May 20237:00 amRNSDirector/PDMR Shareholding
12th May 20237:00 amRNSVesting - Share Matching Scheme/PDMR Shareholdings
11th May 20237:00 amRNSNet Asset Value(s)
20th Apr 20237:00 amRNSHolding(s) in Company
18th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSNet Asset Value(s)
21st Mar 20237:04 amRNSAnnual Financial Report
21st Mar 20237:00 amRNSAnnual Financial Report
6th Feb 20237:00 amRNSTrading Update
6th Feb 20237:00 amRNSTrading Update
3rd Feb 20237:00 amRNSInterest Payment on Unsecured Loan Notes
11th Jan 20237:00 amRNSNet Asset Value(s)
20th Dec 20225:00 pmRNSHolding(s) in Company
15th Dec 20227:00 amRNSNet Asset Value(s)
10th Nov 20227:00 amRNSNet Asset Value(s)
26th Oct 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.